A new project involving Newcastle University experts aims to create better outcomes for patients with blood disorders.
The £35 million scheme, involving scientists from the Northern Institute for Cancer Research, will pull together anonymous patient data to unlock valuable knowledge of life-threatening blood disorders.
Consisting of 51 partners from 11 European countries, the HARMONY project will focus on multiple myeloma, acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, non-Hodgkins lymphoma, myelodysplastic syndromes and blood disorders in infants, children and adults.
The project will build on pre-existing, long-lasting collaborations between academics, clinicians, patient organisations and the pharmaceutical industry.
For the full article please visit the Newcastle University website.